<DOC>
	<DOCNO>NCT00004246</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining chemotherapy radiation therapy may kill tumor cell . PURPOSE : Phase I trial study effectiveness radiation therapy plus fludarabine treating patient locally advanced cancer mouth , pharynx , larynx .</brief_summary>
	<brief_title>Radiation Therapy Plus Fludarabine Treating Patients With Locally Advanced Cancer Mouth , Pharynx , Larynx</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose fludarabine give sixth seventh week radiotherapy patient locally advance squamous cell carcinoma oral cavity , pharynx , larynx , base systemic toxicity drug acute mucosal reaction irradiate field . II . Document qualitative quantitative toxicity combination therapy patient population . OUTLINE : This dose escalation study fludarabine . Patients receive radiotherapy day 1-5 7 week . Patients receive fludarabine IV day 1-5 week 6 7 radiotherapy . Fludarabine administer 3-4 hour prior daily radiotherapy . Cohorts 3 patient receive escalate dos fludarabine maximum tolerate dose ( MTD ) determine . The MTD define dose produce severe toxicity rate near 20 % . Patients follow every 4 week completion treatment acute reaction resolve , every 3 month 2 year , every 4 month 1 year , every 6 month 2 year . PROJECTED ACCRUAL : A maximum 18 patient accrue study within 1.5 year .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma oral cavity , pharynx , larynx surgery would result significant functional impairment Stage III IV ( T34 N23 ) No distant metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : Zubrod 02 Life expectancy : At least 6 month Hematopoietic : Granulocyte count least 1,500/mm3 Platelet count least 150,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL SGOT le 4 time upper limit normal PT/PTT normal Renal : Creatinine great 1.5 mg/dL Other : Not pregnant nursing Fertile patient must use effective contraception No concurrent acute illness infection PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Radiation Therapy</keyword>
	<keyword>RT</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Fludarabine</keyword>
	<keyword>Fludara</keyword>
	<keyword>Fludarabine Phosphate</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
</DOC>